LINC00330 and esophageal squamous cell carcinoma: Additionally, we overexpressed or knocked down CCL2 on the basis of LINC00330 knockdown (Fig. 8D&E, and Additional file 3: Figure S7D&E) and assessed their impact on ESCC cell proliferation, invasion, and EMT.